SML BIOPHARM
Jump to navigation
Jump to search
 | The topic of this article may not meet Wikitia's general notability guideline. |
| Public | |
| Industry | Biotechnology |
| Founded | 2021 |
| Founders |
|
| Headquarters | Gwangmyeong-si , Republic of Korea, |
Area served | Worldwide |
Key people |
|
Number of employees |  13 (2024) |
| Website | www |
SML Biopharm (SML바이오팜) is a South Korean biotechnology company based in Gwangmyeong-si that develops for patient-specific approaches to the treatment of diseases. SML Biopharm aims to become a global leader specializaing in the research and development of next-generation mRNA vaccines. SML Biopharm leads the development of preventing vaccines and therapeutics using cuttingedge mRNA platform technology, pioneering innovations in pharmaceuticals to enhance the health and well-being of humanity in the future.
References
External links
This article "SML BIOPHARM" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.